These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8029815)
21. Glucosamine may retard atherogenesis by promoting endothelial production of heparan sulfate proteoglycans. McCarty MF Med Hypotheses; 1997 Mar; 48(3):245-51. PubMed ID: 9140889 [TBL] [Abstract][Full Text] [Related]
22. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. Benitz WE; Kelley RT; Anderson CM; Lorant DE; Bernfield M Am J Respir Cell Mol Biol; 1990 Jan; 2(1):13-24. PubMed ID: 2137707 [TBL] [Abstract][Full Text] [Related]
23. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin. Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816 [TBL] [Abstract][Full Text] [Related]
24. Chlorate: a reversible inhibitor of proteoglycan sulfation. Humphries DE; Silbert JE Biochem Biophys Res Commun; 1988 Jul; 154(1):365-71. PubMed ID: 2969240 [TBL] [Abstract][Full Text] [Related]
25. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats. Klein DJ; Brown DM; Oegema TR Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of synthesis of heparan sulfate by selenate: possible dependence on sulfation for chain polymerization. Dietrich CP; Nader HB; Buonassisi V; Colburn P FASEB J; 1988 Jan; 2(1):56-9. PubMed ID: 2961646 [TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like domains. A potential mechanism for the anti-atherogenic actions of vascular apolipoprotein e. Paka L; Kako Y; Obunike JC; Pillarisetti S J Biol Chem; 1999 Feb; 274(8):4816-23. PubMed ID: 9988721 [TBL] [Abstract][Full Text] [Related]
30. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II. Tovar AM; de Mattos DA; Stelling MP; Sarcinelli-Luz BS; Nazareth RA; Mourão PA Biochim Biophys Acta; 2005 Apr; 1740(1):45-53. PubMed ID: 15878740 [TBL] [Abstract][Full Text] [Related]
31. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. Ihrcke NS; Platt JL J Cell Physiol; 1996 Sep; 168(3):625-37. PubMed ID: 8816917 [TBL] [Abstract][Full Text] [Related]
32. Basic fibroblast growth factor controls the expression and molecular structure of heparan sulfate in corneal endothelial cells. Schmidt A; Skaletz-Rorowski A; Buddecke E Eur J Biochem; 1995 Dec; 234(2):479-84. PubMed ID: 8536692 [TBL] [Abstract][Full Text] [Related]
33. Alterations of heparan sulfate moieties in cultured endothelial cells exposed to endotoxin. Colburn P; Dietrich CP; Buonassisi V Arch Biochem Biophys; 1996 Jan; 325(1):129-38. PubMed ID: 8554337 [TBL] [Abstract][Full Text] [Related]
34. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells. Vischer P; Feitsma K; Schön P; Völker W Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876 [TBL] [Abstract][Full Text] [Related]
35. Oversulfated fucoidan and heparin suppress endotoxin induction of plasminogen activator inhibitor-1 in cultured human endothelial cells: their possible mechanism of action. Soeda S; Fujii N; Shimeno H; Nagamatsu A Biochim Biophys Acta; 1995 Oct; 1269(1):85-90. PubMed ID: 7578276 [TBL] [Abstract][Full Text] [Related]
36. New electrophoretic and chromatographic techniques for analysis of heparin and heparan sulfate. Viola M; Vigetti D; Karousou E; Bartolini B; Genasetti A; Rizzi M; Clerici M; Pallotti F; De Luca G; Passi A Electrophoresis; 2008 Aug; 29(15):3168-74. PubMed ID: 18633938 [TBL] [Abstract][Full Text] [Related]
37. Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor. Coltrini D; Rusnati M; Zoppetti G; Oreste P; Grazioli G; Naggi A; Presta M Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):583-90. PubMed ID: 7980421 [TBL] [Abstract][Full Text] [Related]
38. Antithrombotic effects of heparin and related agents. Hladovec J; Kornalík F Cor Vasa; 1991; 33(1):68-74. PubMed ID: 1655354 [TBL] [Abstract][Full Text] [Related]
39. Venous and aortic porcine endothelial cells cultured under standardized conditions synthesize heparan sulfate chains which differ in charge. Lowe-Krentz LJ; Joyce JG Anal Biochem; 1991 Mar; 193(2):155-63. PubMed ID: 1872461 [TBL] [Abstract][Full Text] [Related]
40. Effect of heparin and dextran sulfate on the synthesis and structure of heparan sulfate from cultured endothelial cells. Nader HB; Toma L; Pinhal MA; Buonassisi V; Colburn P; Dietrich CP Semin Thromb Hemost; 1991; 17 Suppl 1():47-56. PubMed ID: 2068571 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]